Journal of Renal Nutrition
Volume 18, Issue 5 , Pages 440-447 , September 2008

Long-Term Effect of a Chicken-Based Diet Versus Enalapril on Albuminuria in Type 2 Diabetic Patients With Microalbuminuria

References 

  1. Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225–232
  2. American Diabetes Association: Standards of medical care in diabetes—2007. Position statement. Diabetes Care. 2007;30(Suppl 1):S4–S41
  3. Gross JL, Azevedo MJ, Silveiro SP, et al. Diabetic nephropathy: diagnosis, prevention and treatment. Diabetes Care. 2005;28:164–176
  4. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE Study and MICRO-HOPE Substudy. Lancet. 2000;355:253–259
  5. Parving HH, Lehnert H, Bröchner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870–878
  6. Chan JC, Ko GT, Leung DH, et al. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. Kidney Int. 2000;57:590–600
  7. Walker JD, Bending JJ, Dodds RA, et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet. 1989;2:1411–1415
  8. Hansen HP, Christensen PK, Tauber-Lassen E, et al. Low protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy. Kidney Int. 1999;55:621–628
  9. Pijls LTJ, de Vries H, van Eijk JTM, et al. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Eur J Clin Nutr. 2002;56:1200–1207
  10. Gross JL, Zelmanovitz T, Moulin CC, et al. Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: a randomized crossover trial. Diabetes Care. 2002;25:645–651
  11. de Mello VD, Zelmanovitz T, Perassolo MS, et al. Withdrawal of red meat from the usual diet reduces albuminuria and improves the lipid profile in type 2 diabetic patients with macroalbuminuria. Am J Clin Nutr. 2006;83:1032–1038
  12. Franz MJ, Bantle JP, Beebe CA, et al. American Diabetes Association: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (technical review). Diabetes Care. 2002;25:148–198
  13. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985;27:58–65
  14. Ravid M, Lang R, Rachmani R, et al. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med. 1996;156:286–289
  15. U.S. Department of Agriculture, Agricultural Research Service: USDA national nutrient database for standard reference, release 15. 2002. Nutrient Data Laboratory home page, http://www.nal.usda.gov/fnic/foodcomp
  16. Moulin CC, Tiskievicz F, Zelmanovitz , et al. Use of weighed diet records in the evaluation of diets with different protein contents in patients with type 2 diabetes. Am J Clin Nutr. 1998;67:853–857
  17. Franz MJ, Wheeler ML. Nutrition therapy for diabetic nephropathy. Curr Diab Rep. 2003;3:412–417
  18. Keogh JB, Grieger MN, Clifton PM. Flow-mediated dilatation is impaired by a high saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol. 2005;25:1274–1279
  19. Brown AA, Hu FB. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr. 2001;73:673–686
  20. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int. 2001;59:260–269
  21. Mogensen CE, Viberti G, Halimi S, et al. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension. 2003;41:1063–1071
  22. Sengul AM, Altuntas Y, Kurklu A, et al. Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension. Diabetes Res Clin Pract. 2006;71:210–219
  23. Zatz R, Dunn BR, Meyer TW, et al. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:1925–1930
  24. Ahmad J, Shafique S, Abidi SM, et al. Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects. Diabetes Res Clin Pract. 2003;60:131–138
  25. Rudberg S, Osterby R, Bangstad HJ, et al. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus. Diabetologia. 1999;42:589–595

 Supported by the Ministério de Ciência e Tecnologia, the Conselho Nacional de Desenvolvimento Científico e Tecnológico (MCT/CNPq 502050/2005-5), and the Fundos de Incentivo a Pesquisa e Eventos-Hospital de Clínicas de Porto Alegre. T.P.P. is a recipient of scholarships from the Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

PII: S1051-2276(08)00299-9

doi: 10.1053/j.jrn.2008.04.010

Journal of Renal Nutrition
Volume 18, Issue 5 , Pages 440-447 , September 2008

Article Tools

* Image Usage & Resolution